✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Sympazan is a drug marketed by Aquestive and is included in one NDA. There are two patents protecting this drug.
This drug has one hundred and sixty-two patent family members in nineteen countries.
The generic ingredient in SYMPAZAN is clobazam. There are ten drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the clobazam profile page.
A generic version of SYMPAZAN was approved as clobazam by AMNEAL on October 22nd, 2018.
Summary for SYMPAZAN
|Finished Product Suppliers / Packagers:||1|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price information for SYMPAZAN|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for SYMPAZAN|
|What excipients (inactive ingredients) are in SYMPAZAN?||SYMPAZAN excipients list|
|DailyMed Link:||SYMPAZAN at DailyMed|
SYMPAZAN is protected by two US patents.
Patents protecting SYMPAZAN
See the table below for patents covering SYMPAZAN around the world.
|Country||Patent Number||Title||Estimated Expiration|
|Japan||2006516634||See Plans and Pricing|
|Japan||2011050394||MULTI-LAYER FILM HAVING UNIFORM CONTENT||See Plans and Pricing|
|World Intellectual Property Organization (WIPO)||2007030754||See Plans and Pricing|
|Mexico||2015013184||COMPOSICIONES DE PELICULAS SUBLINGUAL Y BUCAL. (SUBLINGUAL AND BUCCAL FILM COMPOSITIONS.)||See Plans and Pricing|
|Japan||2005528328||See Plans and Pricing|
|Canada||2802671||COMPOSITIONS EN FILM POUR LA DISTRIBUTION D'AGENTS ACTIFS (FILM COMPOSITIONS FOR DELIVERY OF ACTIVES)||See Plans and Pricing|
|Japan||2016513736||舌下及び頬用フィルム組成物||See Plans and Pricing|
|>Country||>Patent Number||>Title||>Estimated Expiration|